Adrenalectomy improves increased carotid intima-media thickness and arterial stiffness in patients with aldosterone producing adenoma

Atherosclerosis

Volumn 221, Issue 1, 2012, Pages 154-159

  Lin, Yen Hung ^a   Lin, Lian Yu ^a   Chen, Aaron ^b   Wu, Xue Ming ^c   Lee, Jen Kuang ^d   Su, Ta Chen ^a   Wu, Vin Cent ^a   Chueh, Shih Chieh ^a,e   Lin, Wei Chou ^a   Lo, Men Tzung ^f   Wang, Pa Chun ^g   Ho, Yi Lwun ^a   Wu, Kwan Dun ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^c TAO YUAN GENERAL HOSPITAL   (Taiwan)

^d FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^e LERNER RESEARCH INSTITUTE   (United States)

^f NATIONAL CENTRAL UNIVERSITY   (Taiwan)

^g CATHAY GENERAL HOSPITAL   (Taiwan)

Author keywords

Adrenalectomy; Aldosterone producing adenoma; Carotid intima media thickness; Primary aldosteronism; Pulse wave velocity

Indexed keywords

ALDOSTERONE; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; POTASSIUM; RENIN; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT;

ADENOMA; ADRENALECTOMY; ADULT; ALDOSTERONE BLOOD LEVEL; ALDOSTERONE PRODUCING ADENOMA; ALDOSTERONE RELEASE; ANTIHYPERTENSIVE THERAPY; ARTERIAL STIFFNESS; ARTERIAL WALL THICKNESS; ARTICLE; B SCAN; BRACHIAL ARTERY; CLINICAL ARTICLE; COMMON CAROTID ARTERY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ESSENTIAL HYPERTENSION; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; MALE; PLASMA RENIN ACTIVITY; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULSE WAVE; SYSTOLIC BLOOD PRESSURE; TREATMENT RESPONSE;

ADRENAL GLAND NEOPLASMS; ADRENALECTOMY; ADRENOCORTICAL ADENOMA; ADULT; ALDOSTERONE; ANALYSIS OF VARIANCE; ANKLE BRACHIAL INDEX; ARTERIES; BIOLOGICAL MARKERS; BLOOD PRESSURE; CAROTID ARTERY DISEASES; CAROTID INTIMA-MEDIA THICKNESS; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; ELASTICITY; FEMALE; HEMODYNAMICS; HUMANS; HYPERALDOSTERONISM; HYPERTENSION; MALE; MIDDLE AGED; POTASSIUM; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PULSATILE FLOW; RENIN; TAIWAN; TIME FACTORS; TREATMENT OUTCOME;

EID: 84857032755     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.12.003     Document Type: Article

References (43)

1. De Rosa M., Galatola M., Quaglietta L., et al. Alu-mediated genomic deletion of the serine/threonine protein kinase 11 (STK11) gene in Peutz-Jeghers syndrome. Gastroenterology 2010, 138:2558-2560.
2. Kuo C.C., Wu V.C., Tsai C.W., Wu K.D. Relative kidney hyperfiltration in primary aldosteronism: a meta-analysis. J Renin Angiotensin Aldosterone Syst 2011, 12:113-122.
3. Wu V.C., Yang S.Y., Lin J.W., et al. Kidney impairment in primary aldosteronism. Clin Chim Acta 2011, 412:1319-1325.
4. Rossi G.P., Di Bello V., Ganzaroli C., et al. Excess aldosterone is associated with alterations of myocardial texture in primary aldosteronism. Hypertension 2002, 40:23-27.
5. Rossi G.P., Sacchetto A., Pavan E., et al. Remodeling of the left ventricle in primary aldosteronism due to Conn's adenoma. Circulation 1997, 95:1471-1478.
6. Rossi G.P., Sacchetto A., Visentin P., et al. Changes in left ventricular anatomy and function in hypertension and primary aldosteronism. Hypertension 1996, 27:1039-1045.
7. Tsuchiya K., Yoshimoto T., Hirata Y. Endothelial dysfunction is related to aldosterone excess and raised blood pressure. Endocr J 2009, 56:553-559.
8. Sechi L.A., Colussi G., Di Fabio A., Catena C. Cardiovascular and renal damage in primary aldosteronism: outcomes after treatment. Am J Hypertens 2010, 23:1253-1260.
9. Wu V.C., Kuo C.C., Wang S.M., et al. Primary aldosteronism: changes in cystatin C-based kidney filtration, proteinuria, and renal duplex indices with treatment. J Hypertens 2011, 29:1778-1786.
10. Lin Y.H., Wang S.M., Wu V.C., et al. The association of serum potassium level with left ventricular mass in patients with primary aldosteronism. Eur J Clin Invest 2011, 41:743-750.
11. Tanabe A., Naruse M., Naruse K., et al. Left ventricular hypertrophy is more prominent in patients with primary aldosteronism than in patients with other types of secondary hypertension. Hypertens Res 1997, 20:85-90.
12. Bernini G., Galetta F., Franzoni F., et al. Arterial stiffness, intima-media thickness and carotid artery fibrosis in patients with primary aldosteronism. J Hypertens 2008, 26:2399-2405.
13. Milliez P., Girerd X., Plouin P.F., Blacher J., Safar M.E., Mourad J.J. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol 2005, 45:1243-1248.
14. Strauch B., Petrak O., Wichterle D., Zelinka T., Holaj R., Widimsky J. Increased arterial wall stiffness in primary aldosteronism in comparison with essential hypertension. Am J Hypertens 2006, 19:909-914.
15. Callera G.E., Touyz R.M., Tostes R.C., et al. Aldosterone activates vascular p38MAP kinase and NADPH oxidase via c-Src. Hypertension 2005, 45:773-779.
16. Holaj R., Zelinka T., Wichterle D., Petrak O., Strauch B., Widimsky J. Increased intima-media thickness of the common carotid artery in primary aldosteronism in comparison with essential hypertension. J Hypertens 2007, 25:1451-1457.
17. Mattace-Raso F.U., van der Cammen T.J., Hofman A., et al. Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam study. Circulation 2006, 113:657-663.
18. Kablak-Ziembicka A., Przewlocki T., Pieniazek P., et al. The role of carotid intima-media thickness assessment in cardiovascular risk evaluation in patients with polyvascular atherosclerosis. Atherosclerosis 2010, 209:125-130.
19. Lorenz M.W., Markus H.S., Bots M.L., Rosvall M., Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 2007, 115:459-467.
20. Lin Y.H., Huang K.H., Lee J.K., et al. Factors influencing left ventricular mass regression in patients with primary aldosteronism post adrenalectomy. J Renin Angiotensin Aldosterone Syst 2011, 12:48-53.
21. Catena C., Colussi G., Lapenna R., et al. Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism. Hypertension 2007, 50:911-918.
22. Lin Y.H., Lee H.H., Liu K.L., et al. Reversal of myocardial fibrosis in patients with unilateral hyperaldosteronism receiving adrenalectomy. Surgery 2011, 150:526-533.
23. Strauch B., Petrak O., Zelinka T., et al. Adrenalectomy improves arterial stiffness in primary aldosteronism. Am J Hypertens 2008, 21:1086-1092.
24. Kuo C.C., Wu V.C., Tsai C.W., et al. Combining body mass index and serum potassium to urine potassium clearance ratio is an alternative method to predict primary aldosteronism. Clin Chim Acta 2011, 412:1637-1642.
25. Wu V.C., Chang H.W., Liu K.L., et al. Primary aldosteronism: diagnostic accuracy of the losartan and captopril tests. Am J Hypertens 2009, 22:821-827.
26. Wu V.C., Chueh S.C., Chang H.W., et al. Association of kidney function with residual hypertension after treatment of aldosterone-producing adenoma. Am J Kidney Dis 2009, 54:665-673.
27. Watt G.C., Harrap S.B., Foy C.J., et al. Abnormalities of glucocorticoid metabolism and the renin-angiotensin system: a four-corners approach to the identification of genetic determinants of blood pressure. J Hypertens 1992, 10:473-482.
28. Kuo C.C., Wu V.C., Huang K.H., et al. Verification and evaluation of aldosteronism demographics in the Taiwan Primary Aldosteronism Investigation Group (TAIPAI Group). J Renin Angiotensin Aldosterone Syst 2011, 12:348-357.
29. Wu V.C., Kuo C.C., Chang H.W., et al. Diagnosis of primary aldosteronism: comparison of post-captopril active renin concentration and plasma renin activity. Clin Chim Acta 2010, 411:657-663.
30. Liao C.H., Chueh S.C., Lai M.K., Hsiao P.J., Chen J. Laparoscopic adrenalectomy for potentially malignant adrenal tumors greater than 5cm. J Clin Endocrinol Metab 2006, 91:3080-3083.
31. Nomura K., Toraya S., Horiba N., Ujihara M., Aiba M., Demura H. Plasma aldosterone response to upright posture and angiotensin II infusion in aldosterone-producing adenoma. J Clin Endocrinol Metab 1992, 75:323-327.
32. Novitsky Y.W., Kercher K.W., Rosen M.J., Cobb W.S., Jyothinagaram S., Heniford B.T. Clinical outcomes of laparoscopic adrenalectomy for lateralizing nodular hyperplasia. Surgery 2005, 138:1009-1016. [discussion 1016-1007].
33. Su T.C., Lee Y.T., Chou S., Hwang W.T., Chen C.F., Wang J.D. Twenty-four-hour ambulatory blood pressure and duration of hypertension as major determinants for intima-media thickness and atherosclerosis of carotid arteries. Atherosclerosis 2006, 184:151-156.
34. Kuo H.K., Chen C.Y., Liu H.M., et al. Metabolic risks, white matter hyperintensities, and arterial stiffness in high-functioning healthy adults. Int J Cardiol 2010, 143:184-191.
35. Rundback J.H., Sacks D., Kent K.C., et al. Guidelines for the reporting of renal artery revascularization in clinical trials. American Heart Association. Circulation 2002, 106:1572-1585.
36. Catena C., Colussi G., Nadalini E., et al. Cardiovascular outcomes in patients with primary aldosteronism after treatment. Arch Intern Med 2008, 168:80-85.
37. Bots M.L., Hoes A.W., Koudstaal P.J., Hofman A., Grobbee D.E. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation 1997, 96:1432-1437.
38. Kitamura A., Iso H., Imano H., et al. Carotid intima-media thickness and plaque characteristics as a risk factor for stroke in Japanese elderly men. Stroke 2004, 35:2788-2794.
39. Rosvall M., Janzon L., Berglund G., Engstrom G., Hedblad B. Incident coronary events and case fatality in relation to common carotid intima-media thickness. J Intern Med 2005, 257:430-437.
40. Lorenz M.W., von Kegler S., Steinmetz H., Markus H.S., Sitzer M. Carotid intima-media thickening indicates a higher vascular risk across a wide age range: prospective data from the Carotid Atherosclerosis Progression Study (CAPS). Stroke 2006, 37:87-92.
41. Wang J.G., Staessen J.A., Li Y., et al. Carotid intima-media thickness and antihypertensive treatment: a meta-analysis of randomized controlled trials. Stroke 2006, 37:1933-1940.
42. Napoli C., Bruzzese G., Ignarro L.J., et al. Long-term treatment with sulfhydryl angiotensin-converting enzyme inhibition reduces carotid intima-media thickening and improves the nitric oxide/oxidative stress pathways in newly diagnosed patients with mild to moderate primary hypertension. Am Heart J 2008, 156:1151-1158.
43. Vukusich A., Kunstmann S., Varela C., et al. A randomized, double-blind, placebo-controlled trial of spironolactone on carotid intima-media thickness in nondiabetic hemodialysis patients. Clin J Am Soc Nephrol 2010, 5:1380-1387.